Editas Medicine, Inc.
EDIT
$2.35
-$0.11-4.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 228.00% | 110.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 228.00% | 110.82% | |||
| Cost of Revenue | 38.58% | 22.21% | |||
| Gross Profit | 78.23% | 2.94% | |||
| SG&A Expenses | -7.82% | -4.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.77% | 10.51% | |||
| Operating Income | 42.90% | 3.59% | |||
| Income Before Tax | 77.62% | 52.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 77.62% | 52.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 77.62% | 52.82% | |||
| EBIT | 42.90% | 3.59% | |||
| EBITDA | 44.55% | -0.84% | |||
| EPS Basic | 79.27% | 55.80% | |||
| Normalized Basic EPS | 64.24% | 13.33% | |||
| EPS Diluted | 79.27% | 55.80% | |||
| Normalized Diluted EPS | 64.24% | 13.33% | |||
| Average Basic Shares Outstanding | 7.95% | 6.73% | |||
| Average Diluted Shares Outstanding | 7.95% | 6.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||